
MNMD P/E Ratio
P/E Ratio as of Jun 30, 2025: -6.21
Average-6.90
Median-6.85
Minimum-7.55
Maximum-6.21
-6.21
Past Month+0.74 (10.65%)
The P/E ratio for MNMD is -6.21 as of Jun 30, 2025. This represents a decrease of -62.75% compared to its 12-month average P/E ratio of -16.67. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Mind Medicine MindMed P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Mind Medicine MindMed’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Mind Medicine MindMed to industry peers.
Mind Medicine MindMed P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Mind Medicine MindMed’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Mind Medicine MindMed to industry peers.
MNMD P/E Ratio Insights
See Mind Medicine MindMed’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in MNMD
Order type
Buy in
Order amount
Est. shares
0 shares
MNMD P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $7.48 | -7.16 |
May 1, 2025 | $6.59 | -3.46 |
Apr 25, 2025 | $6.23 | -3.27 |
MNMD End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -6.21 | +135.23% |
2024 | -2.64 | -29.41% |
2022 | -3.74 | -38.39% |
2021 | -6.07 | -86.37% |
2020 | -44.53 | — |
FAQs About Mind Medicine MindMed (MNMD) P/E ratio
The latest P/E ratio of MNMD is -6.21, as of Jun 30, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Mind Medicine MindMed’s last 12-month average P/E ratio is -16.67, compared to its current P/E ratio of -6.21. This reflects a decrease of -62.75%.
Mind Medicine MindMed’s current P/E ratio of -6.21 is lower than its last 12-month average P/E of -16.67. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Mind Medicine MindMed’s average P/E ratio over the last 3 years is -17.43. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Mind Medicine MindMed’s average P/E ratio over the last 5 years is -10.46. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.